The humanised CYP2C19 transgenic mouse exhibits cerebellar atrophy and movement impairment reminiscent of ataxia

AIMS: CYP2C19 transgenic mouse expresses the human CYP2C19 gene in the liver and developing brain, and it exhibits altered neurodevelopment associated with impairments in emotionality and locomotion. Because the validation of new animal models is essential for the understanding of the aetiology and...

Descripción completa

Detalles Bibliográficos
Autores principales: Milosavljević, Filip, Brusini, Irene, Atanasov, Andrea, Manojlović, Marina, Vučić, Marija, Oreščanin‐Dušić, Zorana, Brkljačić, Jelena, Miljević, Čedo, Nikolić‐Kokić, Aleksandra, Blagojević, Duško, Wang, Chunliang, Damberg, Peter, Pešić, Vesna, Tyndale, Rachel F., Ingelman‐Sundberg, Magnus, Jukić, Marin M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10108232/
https://www.ncbi.nlm.nih.gov/pubmed/36536486
http://dx.doi.org/10.1111/nan.12867

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10108232/
https://www.ncbi.nlm.nih.gov/pubmed/36536486
http://dx.doi.org/10.1111/nan.12867

Ejemplares similares